DZP clinical trials

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

This study is testing a new medication called dapirolizumab pegol (DZP) for people with moderate to severe lupus (SLE). It aims to see if DZP, when added to usual treatments, can safely improve their symptoms over a long time.